J&J's Janssen to Work With HHS on Accelerating Coronavirus Vaccine
February 11 2020 - 5:24PM
Dow Jones News
By Josh Beckerman
Johnson & Johnson's Janssen Pharmaceutical Cos. unit will
work with the U.S. Department of Health and Human Services to
accelerate development of a potential novel coronavirus
vaccine.
An expanded collaboration with the Biomedical Advanced Research
and Development Authority "builds on Johnson & Johnson's
multipronged response" to the coronavirus outbreak, the company
said.
The company is "working closely with global partners to screen
its library of antiviral molecules to accelerate the discovery of
potential COVID-19 treatments."
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
February 11, 2020 17:09 ET (22:09 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024
